Clinical Trials
Dostarlimab after Chemoradiation in pts w/locally advanced unresected H&N carcinoma
Disease Type: Head and Neck
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Patients with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville